HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.

Abstract
Hypoxia presents a challenge to anticancer therapy, reducing the efficacy of many available treatments. Photodynamic therapy is particularly susceptible to hypoxia, given that its mechanism relies on oxygen. Herein, we introduce two new osmium-based polypyridyl photosensitizers that are active in hypoxia. The lead compounds emerged from a systematic study of two Os(II) polypyridyl families derived from 2,2'-bipyridine (bpy) or 4,4'-dimethyl-2,2'-bipyridine (dmb) as coligands combined with imidazo[4,5-f][1,10]phenanthroline ligands tethered to n = 0-4 thiophenes (IP-nT). The compounds were characterized and investigated for their spectroscopic and (photo)biological activities. The two hypoxia-active Os(II) photosensitizers had n = 4 thiophenes, with the bpy analogue 1-4T being the most potent. In normoxia, 1-4T had low nanomolar activity (half-maximal effective concentration (EC50) = 1-13 nM) with phototherapeutic indices (PI) ranging from 5500 to 55 000 with red and visible light, respectively. A sub-micromolar potency was maintained even in hypoxia (1% O2), with light EC50 and PI values of 732-812 nM and 68-76, respectively -currently among the largest PIs for hypoxic photoactivity. This high degree of activity coincided with a low-energy, long-lived (0.98-3.6 μs) mixed-character intraligand charge-transfer (3ILCT)/ligand-to-ligand charge-transfer (3LLCT) state only accessible in quaterthiophene complexes 1-4T and 2-4T. The coligand identity strongly influenced the photophysical and photobiological results in this study, whereby the bpy coligand led to longer lifetimes (3.6 μs) and more potent photo-cytotoxicity relative to those of dmb. The unactivated compounds were relatively nontoxic both in vitro and in vivo. The maximum tolerated dose for 1-4T and 2-4T in mice was greater than or equal to 200 mg kg-1, an excellent starting point for future in vivo validation.
AuthorsJohn A Roque 3rd, Patrick C Barrett, Houston D Cole, Liubov M Lifshits, Evan Bradner, Ge Shi, David von Dohlen, Susy Kim, Nino Russo, Gagan Deep, Colin G Cameron, Marta E Alberto, Sherri A McFarland
JournalInorganic chemistry (Inorg Chem) Vol. 59 Issue 22 Pg. 16341-16360 (Nov 16 2020) ISSN: 1520-510X [Electronic] United States
PMID33126792 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Coordination Complexes
  • Photosensitizing Agents
  • Thiophenes
  • Osmium
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Hypoxia (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Coordination Complexes (chemical synthesis, chemistry, pharmacology)
  • Density Functional Theory
  • Drug Screening Assays, Antitumor
  • Humans
  • Osmium (chemistry, pharmacology)
  • Photochemotherapy
  • Photosensitizing Agents (chemical synthesis, chemistry, pharmacology)
  • Thiophenes (chemistry, pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: